Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peginterferon alfa-2a plus adefovir in chronic hepatitis B
NL-OMON24114Recruiting
- Sponsor
- Roche
- Start
- Oct 2005
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of interferon alfa and adefovir dipivoxil in Chronic Hepatitis B (CHB), sponsored by Roche. Primary endpoints: Primary virologic response rate and Predictive markers for primary response. Started Oct 2005; status: recruiting.
02
Drugs
interferon alfaadefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NL-OMON24114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24114.